Cell line · CVCL_4972
MHCC97-H
Cancer cell line, Homo sapiens. Adult hepatocellular carcinoma. 54 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. MHCC97-H. Cell lines, record CVCL_4972. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_4972
On this page
Cell line
As Cellosaurus gives it.
- Name
- MHCC97-H
- Accession
- CVCL_4972
- RRID
- RRID:CVCL_4972
- Synonyms
- MHCC 97-H, MHCC-97H, MHCC97H, MHCC 97-High metastatic
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 39Y
- Category
- Cancer cell line
- Diseases
- Adult hepatocellular carcinoma (NCIt C7956); Adult hepatocellular carcinoma (ORDO Orphanet_210159)
- Parent
- MHCC97 (CVCL_4971)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers54
3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| ZC3H15 in human tumors: a pan-cancer exploration of its clinical significance, molecular function, and association with the tumor immune microenvironment. | Front Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| USP4-Dependent CHAF1B Stabilization Regulates Distinct SETDB1 Ubiquitin States Linked to AKT T308 Signaling and Lipogenic Remodeling in HCC. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative Pan-Cancer Characterization of lncRNA UPK1A-AS1 and Its Role in Hypoxia-Associated Sorafenib Resistance in Hepatocellular Carcinoma. | Anal Cell Pathol (Amst) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Metabolic Reprogramming of NSUN2-Mediated m5C Modification Promotes the Progression of Hepatocellular Carcinoma by Restricting Natural Killer Cell-Mediated Cytotoxicity. | Cancer Commun (Lond) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A trifluoromethyl quinazoline inhibits hepatocellular carcinoma proliferation through HDAC1 binding and multi-target mechanisms. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FKBP52 dictates the dual role of p53 in hepatocellular carcinoma: Mutation-specific prognostic stratification and therapeutic implications. | J Biol Chem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mechanosensors Collaborate to Regulate DNA Damage Repair in Hepatocellular Carcinoma. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting Cuproptosis and Ferroptosis via a ROS-Responsive Nanoplatform for Enhanced Synergistic Therapy Against Hepatocellular Carcinoma. | Antioxidants (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The miR-4512/PDZK1IP1 axis in hepatocellular carcinoma: clinical significance, diagnostic value, and functional validation. | BMC Med Genomics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Master Regulator SMC1A, Stabilized by N6-Methyladenosine Reader IGF2BP1, Promotes HCC Progression Through Facilitating Enhancer-Promoter Interaction of Nestin. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 54
See all 54 papersRelatives9
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | MHCC97 | CVCL_4971 | Cell lines | |
| Derived from it | HCCLM3 | CVCL_6832 | Cell lines | |
| Derived from it | HyCyte MHCC97-H KO-hKLF4 | CVCL_F4IG | Cell lines | |
| Derived from it | HyCyte MHCC97-H stable cell line for hPLAUR overexpression | CVCL_F4Q5 | Cell lines | |
| Derived from it | HyCyte MHCC97-H-Luc | CVCL_E3I0 | Cell lines | |
| Derived from it | MHCC97-H CD44s shRNA | CVCL_VU23 | Cell lines | |
| Derived from it | MHCC97-H Scrm shRNA | CVCL_VU24 | Cell lines | |
| Derived from it | MHCC97-H c-Met shRNA | CVCL_VU22 | Cell lines | |
| Derived from it | MHCC97H-GFP-LC3 | CVCL_A9LY | Cell lines |
Cell banks1
| Cell bank | Catalog number | Status |
|---|---|---|
| EDITGENE | EDC00424 |
Source EDITGENE
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_4972
GET https://conductscience.org/api/cell-lines/v1/CVCL_4972/papers?page=2